MedPath

Effect of Mulberry Leaf Extract on Blood Glucose

Not Applicable
Completed
Conditions
Prediabetic State
Interventions
Dietary Supplement: Mulberry leaf extract
Dietary Supplement: Placebo
Registration Number
NCT01385865
Lead Sponsor
Ewha Womans University
Brief Summary

The purpose of this study is to evaluate the effect of mulberry leaf extract on blood glucose in subjects with impaired fasting glucose.

Detailed Description

The purpose of this study is to evaluate the effect of mulberry leaf extract on blood glucose in subjects with impaired fasting glucose. After 2 weeks run-in period for wash-out, subjects will randomly assigned to two groups, i.e. control group (placebo) or mulberry leaf extract group. They will intake placebo or mulberry leaf extract for 4 weeks. Biomarkers will be analyzed in blood samples in 0 and 4 weeks.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
40
Inclusion Criteria
  • Age: over 20 years
  • Fasting glucose: 100mg/dl ≤ ~ ≤ 125mg/dl
  • HbA1c: < 6.5%
Exclusion Criteria
  • Subject who has taken medicines, Chinese medicines and Health/Functional Foods which can affect glucose metabolism in 30 days prior to screening visit
  • Subject who has taken part in other clinical trials in 30 days prior to screening visit
  • Subject who is pregnant or breast feeding
  • Subject who lost body weight over 4 kg in 30 days prior to screening visit
  • Alcoholic
  • Heavy smoker (≥ 20 cigarettes/day)
  • Subject who has heart failure, coronary artery disease, uncontrolled hypertension (≥ 140/90mmHg), diabetes (fasting blood glucose ≥ 126mg/dL), renal dysfunction, liver failure, hyperthyroidism, hypothyroidism, cancer or mental disease
  • Subject who has an allergy to the ingredients of study product

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
Mulberry leaf extractMulberry leaf extract-
PlaceboPlacebo-
Primary Outcome Measures
NameTimeMethod
Blood glucose change with meal tolerance test0wk
Secondary Outcome Measures
NameTimeMethod
Malondialdehyde0, 4wk
Blood glucose change with meal tolerance test4wk
Insulin and C-peptide changes with meal tolerance test0, 4 wk
Fasting blood glucose0, 4 wk
Insulin0, 4wk
C-peptide0, 4wk
Glycated albumin0, 4wk
High sensitivity C-reactive protein0, 4wk
Oxidized low-density lipoprotein0, 4wk
Lipid profile (triglyceride, total cholesterol, low-density lipoprotein cholesterol, very-low-density lipoprotein cholesterol, high-density lipoprotein cholesterol)0, 4wk

Trial Locations

Locations (1)

Bundang CHA Medical Center

🇰🇷

Seongnam, Gyeonggi-Do, Korea, Republic of

© Copyright 2025. All Rights Reserved by MedPath